JP6674816B2 - Water-in-oil emulsion composition - Google Patents
Water-in-oil emulsion composition Download PDFInfo
- Publication number
- JP6674816B2 JP6674816B2 JP2016068572A JP2016068572A JP6674816B2 JP 6674816 B2 JP6674816 B2 JP 6674816B2 JP 2016068572 A JP2016068572 A JP 2016068572A JP 2016068572 A JP2016068572 A JP 2016068572A JP 6674816 B2 JP6674816 B2 JP 6674816B2
- Authority
- JP
- Japan
- Prior art keywords
- oil
- water
- pigment
- emulsion composition
- oil emulsion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 88
- 239000007762 w/o emulsion Substances 0.000 title claims description 26
- 239000000049 pigment Substances 0.000 claims description 72
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 claims description 38
- 239000002537 cosmetic Substances 0.000 claims description 33
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 30
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 30
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 claims description 30
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 claims description 20
- 150000002148 esters Chemical class 0.000 claims description 20
- 229940114072 12-hydroxystearic acid Drugs 0.000 claims description 19
- 239000002734 clay mineral Substances 0.000 claims description 15
- 239000004094 surface-active agent Substances 0.000 claims description 15
- 239000011787 zinc oxide Substances 0.000 claims description 15
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 14
- 239000002253 acid Substances 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 12
- 239000003795 chemical substances by application Substances 0.000 claims description 11
- 235000021357 Behenic acid Nutrition 0.000 claims description 10
- 229940116226 behenic acid Drugs 0.000 claims description 10
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 claims description 10
- 230000000475 sunscreen effect Effects 0.000 claims description 7
- 239000000516 sunscreening agent Substances 0.000 claims description 7
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 claims description 6
- 239000000454 talc Substances 0.000 claims description 6
- 229910052623 talc Inorganic materials 0.000 claims description 6
- 229910000420 cerium oxide Inorganic materials 0.000 claims description 4
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 claims description 4
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 claims description 4
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims description 4
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 claims description 4
- 229940031709 peg-30-dipolyhydroxystearate Drugs 0.000 claims description 4
- 229910001928 zirconium oxide Inorganic materials 0.000 claims description 4
- 229910044991 metal oxide Inorganic materials 0.000 claims description 2
- 150000004706 metal oxides Chemical class 0.000 claims description 2
- 239000003921 oil Substances 0.000 description 62
- 235000019198 oils Nutrition 0.000 description 50
- 239000010419 fine particle Substances 0.000 description 35
- 230000000052 comparative effect Effects 0.000 description 33
- 239000002245 particle Substances 0.000 description 24
- 238000000926 separation method Methods 0.000 description 24
- 229920001296 polysiloxane Polymers 0.000 description 22
- -1 acyl lactic acid Chemical compound 0.000 description 17
- 239000000843 powder Substances 0.000 description 15
- 238000003860 storage Methods 0.000 description 15
- 238000002360 preparation method Methods 0.000 description 14
- 230000000694 effects Effects 0.000 description 13
- 239000000839 emulsion Substances 0.000 description 12
- 238000009472 formulation Methods 0.000 description 12
- 239000000306 component Substances 0.000 description 10
- 239000004205 dimethyl polysiloxane Substances 0.000 description 9
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 9
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 9
- 230000002776 aggregation Effects 0.000 description 8
- 239000006185 dispersion Substances 0.000 description 8
- 238000004945 emulsification Methods 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 238000004220 aggregation Methods 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 5
- 230000006750 UV protection Effects 0.000 description 5
- 125000000217 alkyl group Chemical group 0.000 description 5
- 238000005520 cutting process Methods 0.000 description 5
- 229940008099 dimethicone Drugs 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- 239000004721 Polyphenylene oxide Substances 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 238000013329 compounding Methods 0.000 description 4
- 239000010445 mica Substances 0.000 description 4
- 229910052618 mica group Inorganic materials 0.000 description 4
- 229940088608 peg-9 polydimethylsiloxyethyl dimethicone Drugs 0.000 description 4
- 229920000570 polyether Polymers 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 150000005846 sugar alcohols Polymers 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229920006037 cross link polymer Polymers 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229940062000 polyglyceryl-2 triisostearate Drugs 0.000 description 3
- 239000001054 red pigment Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 229920002545 silicone oil Polymers 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- 239000001052 yellow pigment Substances 0.000 description 3
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- QHZLMUACJMDIAE-UHFFFAOYSA-N 1-monopalmitoylglycerol Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)CO QHZLMUACJMDIAE-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- 240000008025 Alternanthera ficoidea Species 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical class OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000002211 L-ascorbic acid Substances 0.000 description 2
- 235000000069 L-ascorbic acid Nutrition 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 206010042496 Sunburn Diseases 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- LDDUCKDUDZVHLN-UHFFFAOYSA-N [2-hydroxy-3-[2-hydroxy-3-(16-methylheptadecanoyloxy)propoxy]propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)COCC(O)COC(=O)CCCCCCCCCCCCCCC(C)C LDDUCKDUDZVHLN-UHFFFAOYSA-N 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 238000005054 agglomeration Methods 0.000 description 2
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 229940105990 diglycerin Drugs 0.000 description 2
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 2
- 229940102552 disteardimonium hectorite Drugs 0.000 description 2
- 239000010696 ester oil Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- CBFCDTFDPHXCNY-UHFFFAOYSA-N icosane Chemical compound CCCCCCCCCCCCCCCCCCCC CBFCDTFDPHXCNY-UHFFFAOYSA-N 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 235000013923 monosodium glutamate Nutrition 0.000 description 2
- 235000014593 oils and fats Nutrition 0.000 description 2
- 150000002892 organic cations Chemical class 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 229940048845 polyglyceryl-3 diisostearate Drugs 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- 239000003352 sequestering agent Substances 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 229910021647 smectite Inorganic materials 0.000 description 2
- 229940073490 sodium glutamate Drugs 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 229920003169 water-soluble polymer Polymers 0.000 description 2
- 239000012463 white pigment Substances 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- SGDMQAPHDOAHCO-HAGFTUHFSA-N (1s,3z)-3-[(2e)-2-[(1r,3as,7ar)-1-[(e,2r,5r)-5-ethyl-6-methylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](CC)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C SGDMQAPHDOAHCO-HAGFTUHFSA-N 0.000 description 1
- IRVNEGRHQKGRGD-WPXUHFOISA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;hexadecanoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O IRVNEGRHQKGRGD-WPXUHFOISA-N 0.000 description 1
- DBSABEYSGXPBTA-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O DBSABEYSGXPBTA-RXSVEWSESA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- JSOVGYMVTPPEND-UHFFFAOYSA-N 16-methylheptadecyl 2,2-dimethylpropanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)C(C)(C)C JSOVGYMVTPPEND-UHFFFAOYSA-N 0.000 description 1
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 1
- APLFKSRPKMRPRY-UHFFFAOYSA-N 2-(2,3-dihydroxypropyl)docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCC(C(O)=O)CC(O)CO APLFKSRPKMRPRY-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- QOOALSWUUBYFCT-UHFFFAOYSA-N 2-[2-(7-methyloctanoyloxy)propoxy]propyl 7-methyloctanoate Chemical compound CC(C)CCCCCC(=O)OCC(C)OCC(C)OC(=O)CCCCCC(C)C QOOALSWUUBYFCT-UHFFFAOYSA-N 0.000 description 1
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- DJMBNBIFHBZPFR-UHFFFAOYSA-N 3-(7-methyloctanoyloxy)butyl 7-methyloctanoate Chemical compound C(CCCCCC(C)C)(=O)OCCC(C)OC(CCCCCC(C)C)=O DJMBNBIFHBZPFR-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 229910052582 BN Inorganic materials 0.000 description 1
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N Lactic Acid Natural products CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 1
- 238000012356 Product development Methods 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical group CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 241000519995 Stachys sylvatica Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- VNSBYDPZHCQWNB-UHFFFAOYSA-N calcium;aluminum;dioxido(oxo)silane;sodium;hydrate Chemical compound O.[Na].[Al].[Ca+2].[O-][Si]([O-])=O VNSBYDPZHCQWNB-UHFFFAOYSA-N 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- ZCPCLAPUXMZUCD-UHFFFAOYSA-M dihexadecyl(dimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCC ZCPCLAPUXMZUCD-UHFFFAOYSA-M 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940048820 edetates Drugs 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052809 inorganic oxide Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940091554 lauryl peg-9 polydimethylsiloxyethyl dimethicone Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- DVEKCXOJTLDBFE-UHFFFAOYSA-N n-dodecyl-n,n-dimethylglycinate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC([O-])=O DVEKCXOJTLDBFE-UHFFFAOYSA-N 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 229910000273 nontronite Inorganic materials 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 125000006353 oxyethylene group Chemical group 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 150000002948 pantothenic acids Chemical class 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 229940061571 peg-9 dimethicone Drugs 0.000 description 1
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 239000005426 pharmaceutical component Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229940105297 polyglyceryl-2 diisostearate Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000003405 preventing effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229910000275 saponite Inorganic materials 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229940070720 stearalkonium Drugs 0.000 description 1
- SFVFIFLLYFPGHH-UHFFFAOYSA-M stearalkonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 SFVFIFLLYFPGHH-UHFFFAOYSA-M 0.000 description 1
- 125000005502 stearalkonium group Chemical group 0.000 description 1
- 229940102548 stearalkonium hectorite Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical class [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- 150000005691 triesters Chemical class 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 239000011882 ultra-fine particle Substances 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000010455 vermiculite Substances 0.000 description 1
- 229910052902 vermiculite Inorganic materials 0.000 description 1
- 235000019354 vermiculite Nutrition 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
本発明は、顔料を高濃度に配合した油中水型乳化組成物であって、乳化組成物中に、顔料に由来する色ムラや白スジ、離油の生じない油中水型乳化組成物に関する。 The present invention is a water-in-oil type emulsion composition containing a pigment in a high concentration, in the emulsion composition, color unevenness and white stripes derived from the pigment, a water-in-oil type emulsion composition that does not cause oil separation About.
ファンデーションに代表されるベースメイクアップ化粧料は、シミやくすみ等の肌のトラブルを隠蔽し、自然な肌感のある仕上がりになるものが好まれるようになってきている。このような自然な仕上がりを達成するためには、肌の実際の色調を反映させて、配合する顔料を決定する必要がある。このため、酸化チタンやタルク、酸化鉄等の着色顔料(赤色顔料、黄色顔料、黒色顔料)、雲母チタン等のパール顔料等の複数の顔料を配合した複雑な組成となっている。これらの顔料の粒子径は、色として認識するために可視光線の散乱に最も有効な粒子径に調整される必要がある。例えば、非特許文献1にルチル型酸化チタンを白色顔料として使用するために、粒子径を可視光線の散乱に最も有効な0.2〜0.4μmに調整することが必要であると記載されている。尚、可視光線の散乱に最も有効な粒子径に調整された顔料を、後述する紫外線の散乱に最も有効な粒子径に調整された顔料である微粒子顔料と区別するために、本明細書では便宜上通常サイズの顔料と呼ぶ場合がある。 As base makeup cosmetics represented by foundations, those which hide skin troubles such as spots and dullness and have a natural skin feeling have come to be preferred. In order to achieve such a natural finish, it is necessary to determine the pigment to be incorporated in consideration of the actual color tone of the skin. Therefore, it has a complex composition in which a plurality of pigments such as coloring pigments (red pigment, yellow pigment, black pigment) such as titanium oxide, talc, and iron oxide, and pearl pigments such as mica titanium are blended. The particle size of these pigments needs to be adjusted to the most effective particle size for scattering visible light in order to recognize as a color. For example, Non-Patent Document 1 states that in order to use rutile-type titanium oxide as a white pigment, it is necessary to adjust the particle diameter to 0.2 to 0.4 μm, which is most effective for scattering visible light. I have. Incidentally, in order to distinguish the pigment adjusted to the particle diameter most effective for scattering of visible light from the fine particle pigment which is a pigment adjusted to the particle diameter most effective for scattering of ultraviolet rays described below, in the present specification, for convenience. Sometimes referred to as normal size pigments.
一般的に、化粧料に紫外線防御機能を持たせるためには、紫外線吸収剤、あるいは微粒子化した顔料を紫外線散乱剤として配合する方法がとられる。有機系の紫外線吸収剤の化粧料への配合は汎用された技術であるが、肌荒れなどの皮膚トラブルの原因となる恐れがあり、皮膚への安全性を重視する場合には避けられる傾向にある。一方、微粒子化した顔料の配合は、それ自体の皮膚刺激性が低いことから、皮膚への安全性をより高めた化粧料の処方において主流となりつつある。微粒子化した顔料の代表的なものに、微粒子酸化チタン、微粒子酸化亜鉛がある。微粒子酸化チタンはUVB波をカットするために、微粒子酸化亜鉛はUVA波をカットするために汎用されている。 In general, in order to provide a cosmetic with an ultraviolet protection function, a method of blending an ultraviolet absorber or a finely divided pigment as an ultraviolet scattering agent is used. The blending of organic UV absorbers into cosmetics is a commonly used technology, but it can cause skin troubles such as rough skin, and tends to be avoided when importance is placed on skin safety. . On the other hand, the compounding of finely divided pigments is becoming mainstream in the formulation of cosmetics with higher safety to the skin because of its low skin irritation. Representative examples of finely divided pigments include fine particle titanium oxide and fine particle zinc oxide. Fine particle titanium oxide is generally used for cutting UVB waves, and fine particle zinc oxide is generally used for cutting UVA waves.
非特許文献1には、酸化チタンの粒子径を光の波長より極端に小さいRayleigh散乱の領域にまで微粒子化すると、粒子径の6乗に比例して光散乱が低下していくため、可視光線の透過が起こり、紫外線カット能を有し、かつ透明な塗膜が得られることが記載されている。また、この文献では、紫外線カット能を有する酸化チタンの粒子径は数nm〜数十nmであると記載されている。さらにまた、微粒子化した酸化チタンなどの無機酸化物のナノ粒子は数十m2/g〜数百m2/gと比表面積が大きいために、表面エネルギーを下げようと粒子の凝集が起こりやすいことが記載されている。 Non-Patent Document 1 discloses that when the particle size of titanium oxide is reduced to a Rayleigh scattering region extremely smaller than the wavelength of light, light scattering decreases in proportion to the sixth power of the particle size. It is described that a transparent coating film can be obtained which has an ultraviolet ray cutting ability and an ultraviolet ray cutting ability. Further, in this document, it is described that the particle diameter of titanium oxide having an ultraviolet ray cutting ability is several nm to several tens nm. Furthermore, nanoparticles of inorganic oxides, such as micronized titanium oxide in order tens m 2 / g to several hundred m 2 / g and the specific surface area is large, aggregation of attempts to decrement the surface energy particles is likely to occur It is described.
このように微粒子化した顔料は凝集が起こりやすいので、微粒子化した顔料の分散安定性を確保するためには工夫が必要となる。例えば、特許文献1には、超微粒子化した酸化チタンや酸化亜鉛を安定的に分散した紫外線遮蔽性超微粒子分散体の技術が開示されている。 Since the finely divided pigment is liable to agglomerate, some measures are required to ensure the dispersion stability of the finely divided pigment. For example, Patent Literature 1 discloses a technology of an ultraviolet shielding ultrafine particle dispersion in which ultrafine titanium oxide and zinc oxide are stably dispersed.
様々な通常サイズの顔料を配合したベースメイクアップ化粧料に、さらに、紫外線防御効果を期待して平均粒径が50nm以下の微粒子化した顔料を配合した組成物においては、組成物中に様々な粒子径の顔料が混在した、より粉体の凝集が生じやすい状態となるため、安定性の確保は一層難しいものとなる。微粒子化した顔料は、紫外線散乱効果が高く皮膚刺激性も低いので重要な成分であるが、肌色に調整されたベースメイクアップ化粧料中で凝集すると肉眼でも白い点やスジとして認識できるようになり、化粧料を容器から吐出した時に不快であるばかりか、凝集の程度が進むと塗布した肌上でも白スジが生じて品質上大きな問題となる。 In a composition in which various normal-sized pigments are blended with a base makeup cosmetic and, further, a finely divided pigment having an average particle size of 50 nm or less in anticipation of an ultraviolet protection effect is blended, various compositions are included in the composition. Since pigments having a particle size are mixed and agglomeration of powder is more likely to occur, it is more difficult to ensure stability. Finely divided pigment is an important component because it has a high UV scattering effect and low skin irritation, but when aggregated in a base makeup cosmetic adjusted to skin color, it can be recognized as white spots or streaks by the naked eye. In addition, when the cosmetic is discharged from the container, it is not only unpleasant, but when the degree of coagulation progresses, white streaks occur even on the applied skin, which is a serious problem in quality.
このような中、微粒子化した顔料の、乳化組成物中での分散安定性を向上させるために様々な技術が提案されている。例えば、特許文献2では、微粒子酸化チタンや微粒子酸化亜鉛を内油相に含有させ、外水相にはその他の粉体を含有させ、製造過程において乳化直前にアシル乳酸及び/又はその塩を内油相に添加することを特徴とする水中油型乳化化粧料の製造方法の技術が開示されている。しかし、この技術は水中油型乳化化粧料の技術であり、乳化型の異なる油中水型乳化化粧料への応用は困難である。 Under such circumstances, various techniques have been proposed for improving the dispersion stability of the finely divided pigment in the emulsion composition. For example, in Patent Document 2, fine particles of titanium oxide and fine particles of zinc oxide are contained in an internal oil phase, and other powders are contained in an external water phase. In a manufacturing process, acyl lactic acid and / or a salt thereof are added immediately before emulsification. There is disclosed a technique of a method for producing an oil-in-water emulsified cosmetic which is characterized by being added to an oil phase. However, this technology is a technology of an oil-in-water emulsion cosmetic, and it is difficult to apply it to a water-in-oil emulsion cosmetic of a different emulsion type.
特許文献3には、油中水型乳化化粧料、特にファンデーションなどのメークアップ化粧料や日焼け止め化粧料において、ポリオキシアルキレン・アルキル共変性シリコーン、グルタミン酸ナトリウム、有機変性粘土鉱物、ジイソステアリン酸ジグリセリルを配合することで、特徴的な肌の摩擦挙動を示し、使用感及び乳化安定性に優れるW/O乳化化粧料が得られることが記載されている。また、グルタミン酸ナトリウム、あるいは有機変性粘土鉱物及びジイソステアリン酸ジグリセリルを配合することにより、使用感及び乳化安定性を損なわずに、粉体の分散安定性や組成物の粘度安定性を向上させることができることが記載されている。特許文献3では、ファンデーションや日焼け止め化粧料に配合される粉体の凝集によって発生する色じま(黄色スジや赤色ムラ)の発生を抑制できることが記載されているが十分ではない。 Patent Document 3 discloses a water-in-oil type emulsified cosmetic, particularly a makeup cosmetic such as a foundation and a sunscreen cosmetic, in which polyoxyalkylene / alkyl co-modified silicone, sodium glutamate, organically modified clay mineral, diglyceryl diisostearate are disclosed. Describes that a W / O emulsified cosmetic that exhibits characteristic skin friction behavior and is excellent in use feeling and emulsification stability can be obtained by blending. Also, by incorporating sodium glutamate, or an organically modified clay mineral and diglyceryl diisostearate, it is possible to improve the dispersion stability of the powder and the viscosity stability of the composition without impairing the usability and emulsion stability. It states that it can. Patent Literature 3 describes that the generation of color fringes (yellow stripes and red unevenness) caused by agglomeration of powders blended in foundations and sunscreen cosmetics is not sufficient, but is sufficient.
また、特許文献4では、特定のポリオキシアルキレンメチルグルコシドと粉体と液状油と多価アルコールと水とを特定量組み合わせた無機粉体の凝集抑制を課題とした液状の油中水型乳化メークアップ化粧料の技術が提案されているが、この技術を用いても白スジの発生を抑えるには十分ではない。 Further, Patent Document 4 discloses a liquid water-in-oil type emulsifying make which aims to suppress aggregation of an inorganic powder obtained by combining a specific amount of a specific polyoxyalkylenemethyl glucoside, a powder, a liquid oil, a polyhydric alcohol, and water. Although a technique for up cosmetics has been proposed, the use of this technique is not enough to suppress the occurrence of white streaks.
一方、ベースメイクアップ化粧料に日焼け防止効果も付与する場合は、化粧崩れしにくいと言われる油中水型の乳化型で設計される。しかし、油中水型乳化組成物は水中油型乳化組成物では生じない「離油」現象が発生することがある。「離油」とは、高温下や長期間保存した場合に、油相に含まれる油が排出されて組成物の表面や空隙にたまる現象である。この離油は、水が排出される、いわゆる乳化不良によって生じる分離とは異なる現象であり、油相を構成する構造や組成の不安定性による。離油は、不良品として認識されやすく設計品質上問題となる。離油を解決するための先行技術としては、例えば特許文献5、特許文献6がある。 On the other hand, when imparting a sunburn preventing effect to the base make-up cosmetics, it is designed as a water-in-oil type emulsion which is said to be hard to lose makeup. However, the water-in-oil type emulsion composition may cause an "oil separation" phenomenon which does not occur in the oil-in-water type emulsion composition. The term “oil separation” refers to a phenomenon in which, when stored at a high temperature or for a long period of time, oil contained in an oil phase is discharged and accumulates on the surface or voids of the composition. This oil separation is a phenomenon different from separation caused by so-called poor emulsification, in which water is discharged, and is due to instability of the structure and composition of the oil phase. Oil separation is easily recognized as a defective product and poses a problem in design quality. Prior art for solving oil separation includes, for example, Patent Documents 5 and 6.
本発明は、顔料を高濃度に配合した油中水型乳化組成物中において、色ムラや白スジ及び離油の生じない油中水型乳化組成物を提供することを課題とする。 An object of the present invention is to provide a water-in-oil type emulsion composition which does not cause color unevenness, white stripes, and oil separation in a water-in-oil type emulsion composition containing a pigment at a high concentration.
本発明の主な構成は、次のとおりである。
(1)顔料を15〜30質量%含む油中水型乳化組成物において、
(A)有機変性粘土鉱物
(B)(ベヘン酸/エイコサン二酸)グリセリル
(C)ポリ(12−ヒドロキシステアリン酸)エステル
(D)界面活性剤
(E)油剤
を含有する油中水型乳化組成物。
(2)(C)ポリ(12−ヒドロキシステアリン酸)エステルがジポリヒドロキシステアリン酸PEG−30である(1)に記載の油中水型乳化組成物。
(3)顔料が複数の金属酸化物を混合しヒトの皮膚の色調に調製したものである(1)又は(2)に記載の油中水型乳化組成物。
(4)顔料が酸化チタン、黄酸化鉄、赤酸化鉄、黒酸化鉄、タルク、パール顔料、微粒子酸化チタン、微粒子酸化亜鉛、微粒子酸化セリウム及び微粒子酸化ジルコニウムから選ばれる6種以上である(1)〜(3)のいずれかに記載の油中水型乳化組成物。
(5)ベースメイクアップ化粧料又は日焼け止め化粧料である(1)〜(4)のいずれかに記載の油中水型乳化組成物。
The main configuration of the present invention is as follows.
(1) In a water-in-oil emulsion composition containing 15 to 30% by mass of a pigment,
(A) Organically modified clay mineral (B) (Behenic acid / eicosantioic acid) glyceryl (C) Poly (12-hydroxystearic acid) ester (D) Surfactant (E) Water-in-oil emulsion containing oil agent Stuff.
(2) The water-in-oil emulsion composition according to (1), wherein (C) the poly (12-hydroxystearic acid) ester is PEG-30 dipolyhydroxystearate.
(3) The water-in-oil emulsion composition according to (1) or (2), wherein the pigment is prepared by mixing a plurality of metal oxides to obtain a color of human skin.
(4) Six or more pigments selected from titanium oxide, yellow iron oxide, red iron oxide, black iron oxide, talc, pearl pigment, fine titanium oxide, fine zinc oxide, fine cerium oxide, and fine zirconium oxide (1) The water-in-oil emulsion composition according to any one of (1) to (3).
(5) The water-in-oil emulsion composition according to any one of (1) to (4), which is a base makeup cosmetic or a sunscreen cosmetic.
本発明の構成の油中水型乳化組成物は、保存中に離油が生じず、さらに顔料、特に粒子径を50nm以下のサイズに微粒子化した顔料の凝集に起因する白スジが発生しないため、極めて安定性の高い化粧料とすることができる。また、50℃の苛酷な条件下に保存しても、離油も白スジも発生しない。したがって紫外線防御効果を期待して微粒子化した顔料(微粒子酸化チタン、微粒子酸化亜鉛等)を高配合したベースメイクアップ化粧料や肌色の日焼け止め化粧料等の製品輸送時や、保管時における品質(外観、使用感、日焼け防止効果)低下の不安がない。 Since the water-in-oil emulsion composition of the present invention does not cause oil separation during storage and further does not generate white streaks due to aggregation of pigments, especially pigments having a particle diameter of 50 nm or less, which are finely divided. It is possible to obtain an extremely stable cosmetic. Even when stored under severe conditions of 50 ° C., neither oil release nor white stripes occur. Therefore, when transporting or storing products such as base makeup cosmetics and skin-colored sunscreen cosmetics, which are highly blended with pigments (fine-grained titanium oxide, fine-grained zinc oxide, etc.) that are expected to have an ultraviolet protection effect, Appearance, feeling of use, sunburn prevention effect) No fear of deterioration.
本願は、顔料を15〜30質量%含む油中水型乳化組成物において、(A)有機変性粘土鉱物、(B)(ベヘン酸/エイコサン二酸)グリセリル、(C)ポリ(12−ヒドロキシステアリン酸)エステル、(D)界面活性剤、(E)油剤を含む油中水型乳化組成物に係る発明である。
以下に本発明の構成成分について説明する。
本発明の油中水型乳化組成物は、顔料を15〜30質量%含有する。顔料の種類は、通常化粧料に使用されるものであれば特に制限されない。有色顔料やパール顔料は、肌色を補正する効果やシミ等を隠蔽する効果があるので、油中水型乳化組成物をヒトの皮膚の色調に調整するために配合する。例えば、白色顔料である酸化チタンやタルク、黄色顔料である黄酸化鉄、黒色顔料である黒酸化鉄、赤色顔料であるベンガラなどの酸化鉄、雲母、酸化鉄被覆雲母及び酸化鉄被覆雲母チタンなどのパール顔料、グンジョウ、酸化クロム、カオリン、窒化ホウ素等を例示できる。例えば酸化チタンであれば、肌に塗布した時に白色として認識させるためにはMieの散乱理論に基づき平均粒径を0.15〜0.4μmに調整する。顔料は、シリコーン処理やフッ素処理等を施した表面処理粉体を用いてもよい。また、あらかじめシリコーン油などに分散処理した市販されている分散体を用いてもよい。
The present application relates to a water-in-oil emulsion composition containing 15 to 30% by mass of a pigment, wherein (A) an organically modified clay mineral, (B) glyceryl (behenic acid / eicosantioic acid), and (C) poly (12-hydroxystearin). The present invention relates to a water-in-oil emulsion composition containing (acid) ester, (D) surfactant, and (E) oil.
Hereinafter, the components of the present invention will be described.
The water-in-oil emulsion composition of the present invention contains 15 to 30% by mass of a pigment. The type of pigment is not particularly limited as long as it is usually used for cosmetics. Since colored pigments and pearl pigments have the effect of correcting skin color and the effect of concealing spots, the water-in-oil emulsion composition is blended to adjust the color tone of human skin. For example, white pigments such as titanium oxide and talc, yellow pigments yellow iron oxide, black pigments black iron oxide, red pigments such as red iron oxide, mica, iron oxide-coated mica, and iron oxide-coated mica titanium. Pearl pigment, gunjou, chromium oxide, kaolin, boron nitride and the like. For example, in the case of titanium oxide, the average particle size is adjusted to 0.15 to 0.4 μm based on Mie's scattering theory in order to make it recognized as white when applied to the skin. As the pigment, a surface-treated powder that has been subjected to a silicone treatment or a fluorine treatment may be used. Alternatively, a commercially available dispersion previously dispersed in silicone oil or the like may be used.
本発明の構成をとると、顔料の分散安定性が極めて高いので、分散安定化が難しいとされる微粒子化した顔料を高配合することができる。微粒子化した顔料としては、微粒子酸化チタン、微粒子酸化亜鉛、微粒子酸化セリウム、微粒子酸化ジルコニウム等が例示できる。紫外線防御剤として効果を発揮するためには、Mieの散乱理論に基づき平均粒子径が50nm以下とする。特に、平均粒子径が50nm以下である微粒子酸化チタンと微粒子酸化亜鉛を併用すると、UVB波とUVA波を防御できるので好ましい。また、シリコーンで表面処理(被覆処理)しているものを用いることが好ましい。これらの微粒子化した顔料は、市販されている単体の中から所望する紫外線防御効果に応じて適宜決定される。また、揮発性シリコーン基材中に、安定に低次粒子化されたペースト状の市販品を用いても良い。このような市販品としては大日本化成(株)製のコスメサーブWP−40TK、コスメサーブWP−TTN(V)を例示できる。
コスメサーブWP−40TKは微粒子酸化チタン30質量%、シクロペンタシロキサン50質量%、PEG−9ポリジメチルシロキシエチルジメチコン10質量%、その他10質量%を占める成分(水酸化アルミ、シリカおよび(ジメチコン/ビニルジメチコン)クロスポリマー)から成る。
コスメサーブWP−TTN(V)は微粒子酸化チタン23質量%、シクロペンタシロキサン66質量%、ジイソステアリン酸ポリグリセリル−2が2質量%、その他8質量%を占める成分(水酸化アルミ、ステアリン酸および(ジメチコン/ビニルジメチコン)クロスポリマー)から成る。
微粒子化した顔料の種類と配合量は、所望する紫外線防御効果に応じて適宜決定される。微粒子顔料の配合量は、純分として好ましくは4〜20質量%、より好ましくは4〜16質量%配合するとよい。4質量%未満だと十分な紫外線防御効果が得られない。微粒子顔料の配合量は、本発明の顔料の配合量で示した15〜30質量%に含まれる。
According to the constitution of the present invention, the dispersion stability of the pigment is extremely high, so that a finely divided pigment, which is considered to be difficult to stabilize the dispersion, can be highly blended. Examples of the finely divided pigment include fine particle titanium oxide, fine particle zinc oxide, fine particle cerium oxide, and fine particle zirconium oxide. In order to exhibit the effect as an ultraviolet ray protective agent, the average particle size is set to 50 nm or less based on Mie's scattering theory. In particular, it is preferable to use a fine particle titanium oxide and a fine particle zinc oxide having an average particle diameter of 50 nm or less because UVB waves and UVA waves can be protected. Further, it is preferable to use a material that has been surface-treated (coated) with silicone. These finely divided pigments are appropriately determined from commercially available simple substances according to the desired ultraviolet protection effect. Alternatively, a paste-like commercially available product in which a low-order particle is stably formed in a volatile silicone base material may be used. Examples of such commercially available products include Cosmeserve WP-40TK and Cosmeserve WP-TTN (V) manufactured by Dainippon Kasei Co., Ltd.
Cosmeserve WP-40TK contains 30% by mass of fine particle titanium oxide, 50% by mass of cyclopentasiloxane, 10% by mass of PEG-9 polydimethylsiloxyethyl dimethicone, and other components occupying 10% by mass (aluminum hydroxide, silica and (dimethicone / vinyl). Dimethicone) crosspolymer).
Cosmeserve WP-TTN (V) contains 23% by mass of fine-particle titanium oxide, 66% by mass of cyclopentasiloxane, 2% by mass of polyglyceryl-2 diisostearate, and 8% by mass of other components (aluminum hydroxide, stearic acid and (dimethicone) / Vinyl dimethicone) crosspolymer).
The type and amount of the finely divided pigment are appropriately determined according to the desired ultraviolet protection effect. The compounding amount of the fine particle pigment is preferably 4 to 20% by mass, more preferably 4 to 16% by mass as a pure component. If it is less than 4% by mass, a sufficient ultraviolet ray protection effect cannot be obtained. The compounding amount of the fine particle pigment is included in the range of 15 to 30% by mass indicated by the compounding amount of the pigment of the present invention.
組成物をヒトの皮膚の色調とするために選択される顔料の種類と好ましい配合量を以下に例示する。
ア)白色顔料:酸化チタン(平均粒子径150〜400nm) 5〜10質量%
イ)黄色顔料:黄酸化鉄 1〜2質量%
ウ)赤色顔料:赤酸化鉄(ベンガラ) 0.1〜0.5質量%
エ)黒色顔料:黒酸化鉄 0.05〜0.5質量%
尚、使用感などの調整のため、タルクを配合する場合は、酸化チタンの配合量の一部をタルクに置き換えるとよい。
また、UVB波とUVA波を防御するために、前記顔料と併用して配合する微粒子酸化チタンと微粒子酸化亜鉛の好ましい配合量を以下に例示する。
(微粒子顔料)
オ)微粒子酸化チタン(平均粒子径1〜50nm) 4〜16質量%
カ)微粒子酸化亜鉛(平均粒子径1〜50nm) 1〜5質量%
尚、微粒子酸化セリウム、微粒子酸化ジルコニウムを配合する場合は、微粒子酸化チタンの配合量の一部を置き換えるとよい。
本発明の構成をとると、ア〜カの顔料を白スジが発生することなく、安定に配合できる。
The types of pigments selected for making the composition have the color of human skin and the preferred amounts are as follows.
A) White pigment: titanium oxide (average particle diameter 150 to 400 nm) 5 to 10% by mass
I) Yellow pigment: 1-2% by mass of yellow iron oxide
C) Red pigment: red iron oxide (red iron) 0.1 to 0.5% by mass
D) Black pigment: 0.05 to 0.5% by mass of black iron oxide
When talc is blended for adjusting the feeling of use, a part of the blending amount of titanium oxide may be replaced with talc.
Preferred amounts of the fine particle titanium oxide and the fine particle zinc oxide, which are used in combination with the pigment to protect the UVB wave and the UVA wave, are exemplified below.
(Fine particle pigment)
E) Fine particle titanium oxide (average particle diameter 1 to 50 nm) 4 to 16% by mass
F) Fine particle zinc oxide (average particle diameter 1-50 nm) 1-5% by mass
In addition, when fine-particle cerium oxide and fine-particle zirconium oxide are blended, a part of the blending amount of fine-particle titanium oxide may be replaced.
According to the constitution of the present invention, the pigments A to A can be stably blended without generating white stripes.
(A)有機変性粘土鉱物
本発明には、有機変性粘土鉱物を必須成分として配合する。膨潤性層状ケイ酸塩であるスメクタイトは、陽イオン性粘土鉱物であり、その陽イオンを第四級アンモニウム塩等の有機カチオンで置換したものは、有機変性粘土鉱物と呼ばれる。スメクタイトに含まれる鉱物として、ヘクトライト、モンモリロナイト、ベントナイト、サポナイト、バイデライト、ノントロナイト、スチブンサイト、バーミキュライト、ボルコンスコイト、ソコナイト、マガダイト、ケニアライト等が挙げられる。有機カチオンとしては、ジメチルジステアリルアンモニウムクロライド、ジメチルジパルミチルアンモニウムクロライド、ステアリルベンジルジメチルアンモニウムクロライド、ステアリルトリメチルアンモニウムクロライド、ラウリルジメチルアミノ酢酸ベタイン等が挙げられる。有機変性粘土鉱物としては、ジステアルジモニウムヘクトライト、ステアラルコニウムヘクトライト、ステアラルコニウムベントナイト等が挙げられる。本発明に用いる有機変性粘土鉱物は、ジステアルジモニウムヘクトライトが特に好ましい。
(A) Organically modified clay mineral In the present invention, an organically modified clay mineral is blended as an essential component. Smectite, which is a swellable layered silicate, is a cationic clay mineral, and the cation replaced with an organic cation such as a quaternary ammonium salt is called an organically modified clay mineral. The minerals contained in smectite include hectorite, montmorillonite, bentonite, saponite, beidellite, nontronite, stevensite, vermiculite, vorconscoite, soconite, magadite, Kenyalite and the like. Examples of the organic cation include dimethyl distearyl ammonium chloride, dimethyl dipalmityl ammonium chloride, stearyl benzyl dimethyl ammonium chloride, stearyl trimethyl ammonium chloride, betaine lauryl dimethyl amino acetate, and the like. Examples of the organically modified clay mineral include disteardimonium hectorite, stearalkonium hectorite, and stearalkonium bentonite. As the organically modified clay mineral used in the present invention, disteardimonium hectorite is particularly preferred.
本発明に用いる有機変性粘土鉱物の配合量は0.1〜5質量%が好ましい。0.1質量%未満では、効果が不十分な場合があり、5質量%を超えて配合すると、べたついた使用感になる恐れがある。 The amount of the organically modified clay mineral used in the present invention is preferably 0.1 to 5% by mass. If the amount is less than 0.1% by mass, the effect may be insufficient. If the amount is more than 5% by mass, a sticky feeling may be caused.
(B)(ベヘン酸/エイコサン二酸)グリセリル
本発明に使用する(ベヘン酸/エイコサン二酸)グリセリルは、ベヘン酸、エイコサン二酸とグリセリンからなるオリゴマーエステルであり、白色〜淡黄色のロウ状固体の油性増粘剤である。(ベヘン酸/エイコサン二酸)グリセリルの配合量は1〜5質量%が好ましい。
(B) (Behenic acid / eicosantioic acid) glyceryl The glyceryl (behenic acid / eicosantioic acid) used in the present invention is an oligomer ester composed of behenic acid, eicosantioic acid and glycerin, and is a white to pale yellow wax. It is a solid oily thickener. The blending amount of (behenic acid / eicosane diacid) glyceryl is preferably 1 to 5% by mass.
(C)ポリ(12−ヒドロキシステアリン酸)エステル
本発明に使用する、ポリ(12−ヒドロキシステアリン酸)エステルは、ポリ(12−ヒドロキシステアリン酸)エステルは、多価アルコールをアルカリ存在下、ポリ(12−ヒドロキシステアリン酸)に、塩化チオニル等のハロゲン化剤を反応させて調製した、酸クロライドを反応させることにより得ることができる。
多価アルコ−ルとしては、プロピレングリコール、ブタンジオール、ペンタンジオール、(ポリ)グリセリン、(ポリ)プロピレングリコール、ポリエチレングリコールなどが好ましく例示でき、ポリエチレングリコールが特に好ましい。この場合のポリエチレングリコールのサイズは、平均分子量で400〜6000が好ましい。一方、疎水基となるポリ(12−ヒドロキシステアリン酸)は、そのサイズが平均分子量1000〜3000であることが好ましい。
ポリエチレングリコールのジ(12−ヒドロキシステアリン酸)エステルは、INCI名がジポリヒドロキシステアリン酸PEG−30と収載されているものが好ましく、市販品としては、ユニケマ社製のアラセルP−135、クローダジャパン(株)社製のシスロールDPHS等が挙げられる。ジポリヒドロキシステアリン酸PEG−30を配合する場合は、0.1〜3質量%が好ましく、特に好ましくは0.5〜1質量%である。0.1質量%に満たないと、本発明の効果が十分に発揮されない恐れがある。3質量%を超えると、べたついた使用感になる恐れがある。
(C) Poly (12-hydroxystearic acid) ester The poly (12-hydroxystearic acid) ester used in the present invention is a poly (12-hydroxystearic acid) ester. 12-hydroxystearic acid) with an acid chloride prepared by reacting a halogenating agent such as thionyl chloride.
Preferred examples of the polyhydric alcohol include propylene glycol, butanediol, pentanediol, (poly) glycerin, (poly) propylene glycol, and polyethylene glycol, and polyethylene glycol is particularly preferred. In this case, the polyethylene glycol preferably has an average molecular weight of 400 to 6000. On the other hand, it is preferable that the poly (12-hydroxystearic acid) to be a hydrophobic group has an average molecular weight of 1,000 to 3,000.
As the di (12-hydroxystearic acid) ester of polyethylene glycol, those listed under the INCI name PEG-30 dipolyhydroxystearate are preferable, and as commercial products, Alacel P-135 manufactured by Unichema, Clauda Japan And cis-roll DPHS manufactured by K.K. When PEG-30 dipolyhydroxystearate is blended, the content is preferably 0.1 to 3% by mass, particularly preferably 0.5 to 1% by mass. If the amount is less than 0.1% by mass, the effect of the present invention may not be sufficiently exerted. If the amount exceeds 3% by mass, a sticky feeling may be caused.
(D)界面活性剤
本発明の乳化型は油中水型である。乳化に用いる界面活性剤は、乳化型が油中水型となるものであればいずれでもよいが、前述した(C)のポリ(12−ヒドロキシステアリン酸)エステル(界面活性剤)とは別に配合する。本発明に使用する界面活性剤としては、使用感が良いことからシリコーン分岐型ポリエーテル変性シリコーン、シリコーン分岐型アルキル共変性ポリエーテル変性シリコーン、シリコーン分岐型ポリグリセリン変性シリコーン、ポリエーテル変性シリコーン等のシリコーン系界面活性剤を好ましく例示できる。
シリコーン分岐型ポリエーテル変性シリコーンは、ポリジメチルシロキサンを骨格として、これに−C3H6−O−(C2H4O)nHで表されるポリエーテル基が上記のポリジメチルシロキサン骨格のSiに側鎖として複数結合している。すなわち、−C2H4−(Si(CH3)2O)n−Si(CH3)3で表されるシリコーン基が側鎖としてポリジメチルシロキサン骨格のSiに複数結合した化合物である。このようなシリコーン分岐型ポリエーテル変性シリコーンは市販品を用いることができる。例えば信越化学工業(株)製のPEG−9ポリジメチルシロキシエチルジメチコン(商品名:KF−6028)が挙げられる。
シリコーン分岐型アルキル共変性ポリエーテル変性シリコーンは、ポリジメチルシロキサンを骨格として、これに炭素数2以上のアルキル基が側鎖としてポリジメチルシロキサン骨格のSiに複数結合したものである。側鎖として、−C3H6−O−(C2H4O)nHで表されるポリエーテル基が上記と同様にポリジメチルシロキサン骨格のSiに複数結合している。このようなシリコーン分岐型アルキル共変性ポリエーテル変性シリコーンとしては市販品を用いることができる。例えば信越化学工業(株)製のラウリルPEG−9ポリジメチルシロキシエチルジメチコン(商品名:KF−6038)が挙げられる。
シリコーン分岐型ポリグリセリン変性シリコーンは、ポリジメチルシロキサンを骨格として、これに−C3H6−O−(CH2CH(OH)CH2O)nHで表されるポリエーテル基が上記のポリジメチルシロキサン骨格のSiに複数結合したものである。このようなシリコーン分岐型ポリグリセリン変性シリコーンとしては市販品を用いることができる。例えば信越化学工業(株)製のポリグリセリル−3ポリジメチルシロキシエチルジメチコン(商品名:KF−6104)が挙げられる。ポリエーテル変性シリコーンとしては、信越化学工業(株)製のPEG−9ジメチコン(商品名:KF−6019)が挙げられる。
また、高重合、低HLBのポリ(オキシエチレン・オキシプロピレン)共重合体をシクロペンタシロキサンに溶解させたシリコーン系界面活性剤も好ましく例示できる。例えば、東レ・ダウコーニング(株)製のシリコーンBY22−008Mが挙げられる。また、ポリグリセリン脂肪酸エステルも好ましく例示できる。例えば、イソステアリン酸とジグリセリンのトリエステルであるトリイソステアリン酸ポリグリセリル−2(商品名:EMALEX TISG−2)などが挙げられる。
本発明に用いる界面活性剤は、それぞれを単独で配合しても良いし、2種又は3種を混合しても良い。また配合量は、適宜設定することができる。
(D) Surfactant The emulsion type of the present invention is a water-in-oil type. The surfactant used for the emulsification may be any as long as the emulsification type is a water-in-oil type, but is blended separately from the aforementioned poly (12-hydroxystearic acid) ester (surfactant) of (C). I do. As the surfactant used in the present invention, silicone-branched polyether-modified silicone, silicone-branched alkyl co-modified polyether-modified silicone, silicone-branched polyglycerin-modified silicone, polyether-modified silicone, etc. A preferred example is a silicone-based surfactant.
Silicone branched polyether-modified silicone, a polydimethylsiloxane as a scaffold, polyether group of the polydimethylsiloxane skeleton represented by this -C 3 H 6 -O- (C 2 H 4 O) n H A plurality is bonded to Si as side chains. That, -C 2 H 4 - is a (Si (CH 3) 2 O ) n-Si (CH 3) compound silicone group represented by 3 is more bound to Si polydimethylsiloxane backbone as side chains. Commercial products can be used for such a silicone-branched polyether-modified silicone. An example is PEG-9 polydimethylsiloxyethyl dimethicone (trade name: KF-6028) manufactured by Shin-Etsu Chemical Co., Ltd.
The silicone-branched alkyl co-modified polyether-modified silicone has polydimethylsiloxane as a skeleton, and a plurality of alkyl groups having 2 or more carbon atoms are bonded to Si of the polydimethylsiloxane skeleton as side chains. As a side chain, polyether groups are more bound to Si of the same polydimethylsiloxane skeleton represented by -C 3 H 6 -O- (C 2 H 4 O) n H. Commercial products can be used as such a silicone-branched alkyl co-modified polyether-modified silicone. For example, Lauryl PEG-9 polydimethylsiloxyethyl dimethicone (trade name: KF-6038) manufactured by Shin-Etsu Chemical Co., Ltd. may be mentioned.
The silicone-branched polyglycerin-modified silicone has polydimethylsiloxane as a skeleton, and a polyether group represented by —C 3 H 6 —O— (CH 2 CH (OH) CH 2 O) n H is added to the above-mentioned polyether. It is one bonded to a plurality of Si in the dimethylsiloxane skeleton. Commercial products can be used as such a silicone-branched polyglycerin-modified silicone. For example, polyglyceryl-3 polydimethylsiloxyethyl dimethicone (trade name: KF-6104) manufactured by Shin-Etsu Chemical Co., Ltd. may be mentioned. Examples of the polyether-modified silicone include PEG-9 dimethicone (trade name: KF-6019) manufactured by Shin-Etsu Chemical Co., Ltd.
Further, a silicone-based surfactant obtained by dissolving a high polymerization and low HLB poly (oxyethylene / oxypropylene) copolymer in cyclopentasiloxane is also preferably exemplified. For example, silicone BY22-008M manufactured by Dow Corning Toray Co., Ltd. may be used. Further, polyglycerin fatty acid esters can also be preferably exemplified. For example, polyglyceryl-2 triisostearate (trade name: EMALEX TISG-2), which is a triester of isostearic acid and diglycerin, may be mentioned.
The surfactants used in the present invention may be used alone or in combination of two or three. Further, the amount can be appropriately set.
(E)油剤
本発明に使用する油剤としては、エステル油、植物油のような油脂類、炭化水素類、シリコ−ン油などが例示できる。常温で液状であることが好ましい。
エステル油としては、例えば、エチルヘキサン酸セチル、ジイソノナン酸1,3−ブチレングリコール、ジ2−エチルヘキサン酸1,3−ブチレングリコール、ジイソノナン酸ジプロピレングリコール、ジ2−エチルヘキサン酸ジプロピレングリコール、イソノナン酸イソノニル、トリ2−エチルヘキサン酸グリセリル、トリカプリン酸グリセリル、トリイソステアリン酸グリセリル、ジカプリン酸ネオペンチルグリコール、パルミチン酸エチルヘキシル、ネオペンタン酸イソステアリル等が挙げられる。油脂類としては、例えば、ツバキ油、月見草油、マカデミアナッツ油、オリーブ油、ナタネ油、トウモロコシ油、ゴマ油、ホホバ油、胚芽油、小麦胚芽油、等の液体油脂等が挙げられる。炭化水素類としては、例えば、流動パラフィン、スクワレン、スクワラン等が挙げられる。シリコ−ン油としては、例えば、ジメチルポリシロキサン、メチルフェニルポリシロキサン等の鎖状ポリシロキサン、デカメチルシクロペンタシロキサン、シクロペンタシロキサン等の環状ポリシロキサンが挙げられる。本発明の構成をとることで離油を生じないので、(D)油剤を多く配合することができる。その結果、粉体が多い処方であっても、しっとりとした使用感が得られる。本発明において、(D)油剤は、20〜50質量%、より好ましくは30〜50質量%であることが好ましい。
(E) Oil agent Examples of the oil agent used in the present invention include oils and fats such as ester oil and vegetable oil, hydrocarbons, and silicone oil. It is preferably liquid at room temperature.
Examples of ester oils include cetyl ethylhexanoate, 1,3-butylene glycol diisononanoate, 1,3-butylene glycol di-2-ethylhexanoate, dipropylene glycol diisononanoate, dipropylene glycol di-2-ethylhexanoate, Examples include isononyl isononanoate, glyceryl tri-2-ethylhexanoate, glyceryl tricaprate, glyceryl triisostearate, neopentyl glycol dicaprate, ethylhexyl palmitate, and isostearyl neopentanoate. Examples of oils and fats include liquid oils such as camellia oil, evening primrose oil, macadamia nut oil, olive oil, rapeseed oil, corn oil, sesame oil, jojoba oil, germ oil, wheat germ oil, and the like. Examples of the hydrocarbons include liquid paraffin, squalene, squalane, and the like. Examples of the silicone oil include chain polysiloxanes such as dimethylpolysiloxane and methylphenylpolysiloxane, and cyclic polysiloxanes such as decamethylcyclopentasiloxane and cyclopentasiloxane. Since oil separation does not occur by adopting the configuration of the present invention, (D) a large amount of oil agent can be blended. As a result, a moist feeling of use can be obtained even with a formulation containing a large amount of powder. In the present invention, the oil agent (D) preferably accounts for 20 to 50% by mass, more preferably 30 to 50% by mass.
本発明の油中水型乳化組成物の粘度は、東機産業(株)製のTV25型粘度計(25℃、4号ローター、12rpm、30秒)で測定した時に10,000〜100,000mPa・sである。 The viscosity of the water-in-oil emulsion composition of the present invention is 10,000 to 100,000 mPa when measured with a TV25 viscometer manufactured by Toki Sangyo Co., Ltd. (25 ° C., No. 4 rotor, 12 rpm, 30 seconds). -It is s.
本発明の油中水型乳化組成物には、任意成分として本発明の効果を損なわない範囲で、化粧料に通常用いられている成分、例えば、有機粉体、水溶性高分子、多価アルコール等の保湿剤、塩類、pH調整剤、防腐剤、金属イオン封鎖剤、薬効成分、香料等を配合することができる。また、アスコルビン酸誘導体、セラミド、植物抽出液等の美容成分を配合することができる。 The water-in-oil emulsified composition of the present invention includes components commonly used in cosmetics, as long as the effects of the present invention are not impaired as optional components, such as organic powders, water-soluble polymers, and polyhydric alcohols. Humectants, salts, pH adjusters, preservatives, sequestering agents, medicinal ingredients, fragrances and the like. In addition, cosmetic ingredients such as ascorbic acid derivatives, ceramides and plant extracts can be added.
有機粉体としては、ポリメタクリル酸メチル樹脂(PMMA)等のポリマービーズやポリシリコーン1クロスポリマーなどのシリコーン樹脂粉体、ポリウレタン粉体等を配合することができる。 As organic powder, polymer beads such as polymethyl methacrylate resin (PMMA), silicone resin powder such as polysilicone 1 crosspolymer, polyurethane powder, and the like can be blended.
水溶性高分子としては、アラビアガム、トラガカントガム、ガラクタン、グアーガム、カラギーナン、ペクチン、寒天、クインスシード、デキストラン、プルラン、カルボキシメチルデンプン、コラーゲン、カゼイン、ゼラチン、メチルセルロース、メチルヒドロキシプロピルセルロース、ヒドロキシエチルセルロース、カルボキシメチルセルロースナトリウム、アルギン酸ナトリウム、カルボキシビニルポリマー等を例示できる。 Water-soluble polymers include gum arabic, tragacanth gum, galactan, guar gum, carrageenan, pectin, agar, quince seed, dextran, pullulan, carboxymethyl starch, collagen, casein, gelatin, methyl cellulose, methyl hydroxypropyl cellulose, hydroxyethyl cellulose, carboxy. Examples thereof include sodium methylcellulose, sodium alginate, and carboxyvinyl polymer.
多価アルコールとしては、グリセリン、ジグリセリン、1,2−ペンタンジオール、ジプロピレングリコール、1,3−ブチレングリコール等を例示できる。 Examples of the polyhydric alcohol include glycerin, diglycerin, 1,2-pentanediol, dipropylene glycol, 1,3-butylene glycol and the like.
塩類としては、塩化ナトリウム、硫酸マグネシウム等を例示できる。 Examples of the salts include sodium chloride and magnesium sulfate.
pH調整剤としては、クエン酸、クエン酸ナトリウム、リン酸、リン酸ナトリウム等を例示できる。 Examples of the pH adjuster include citric acid, sodium citrate, phosphoric acid, sodium phosphate and the like.
防腐剤としては、メチルパラベン、エチルパラベン等を例示できる。 Examples of the preservative include methyl paraben, ethyl paraben and the like.
金属イオン封鎖剤としては、エチレンジアミン四酢酸二ナトリウム、エデト酸、エデト酸ナトリウム塩等のエデト酸塩を例示できる。 Examples of the sequestering agent include edetates such as disodium ethylenediaminetetraacetate, edetic acid, and edetate sodium salt.
薬効成分としては、ビタミンA油、レチノール等のビタミンA類、リボフラビン等のビタミンB6類、ピリドキシン塩酸塩等のB6類、L−アスコルビン酸、L−アスコルビン酸リン酸エステル、L−アスコルビン酸モノパルミチン酸エステル、L−アスコルビン酸ジパルミチン酸エステル、L−アスコルビン酸−2−グルコシド等のビタミンC類、パントテン酸カルシウム等のパントテン酸類、ビタミンD6、コレカルシフェロール等のビタミンD類、α−トコフェロール、酢酸トコフェロール、ニコチン酸DL−α−トコフェロール等のビタミンE類等のビタミン類を例示できる。 Pharmaceutical components include vitamin A oil, vitamin A such as retinol, vitamin B6 such as riboflavin, B6 such as pyridoxine hydrochloride, L-ascorbic acid, L-ascorbic acid phosphate, and L-ascorbic acid monopalmitin. Acid esters, L-ascorbic acid dipalmitate, vitamin Cs such as L-ascorbic acid-2-glucoside, pantothenic acids such as calcium pantothenate, vitamin D6, vitamin Ds such as cholecalciferol, α-tocopherol, Vitamins such as vitamin Es such as tocopherol acetate and DL-α-tocopherol nicotinate can be exemplified.
本発明の油中水型乳化組成物は、その特性から、化粧下地やベースメイクアップファンデーションなどのベースメイクアップ化粧料、色のついた日焼け止め化粧料として用いることが最適である。また皮膚外用剤として医薬部外品や医薬品として使用することができる。 The water-in-oil emulsion composition of the present invention is optimally used as a base makeup cosmetic such as a makeup base or a base makeup foundation or a colored sunscreen cosmetic because of its properties. In addition, it can be used as a quasi-drug or pharmaceutical as an external preparation for skin.
以下に実施例、比較例を用いた試験例を示し、本発明をさらに詳しく説明する。
1.試験品の調製
下記表1(実施例1〜6)、表2(比較例1〜11)の組成の油中水型乳組成物(ベースメイクアップ化粧料)を以下の調製方法により調製した。
なお比較例1は(A)有機変性粘土鉱物を配合しない処方である。比較例2、3は、(B)ベヘン酸/エイコサン二酸)グリセリルを配合しない処方であり、比較例2はベヘン酸/エイコサン二酸)グリセリルに代えて油性増粘剤であるパルミチン酸デキストリンを配合した処方である。比較例4〜11は(C)ポリ(12−ヒドロキシステアリン酸)エステルを配合しない処方であるが、比較例4はもともと処方されていた界面活性剤(PEG−9ポリジメチルシロキシエチルジメチコン)を増量させた処方であり、比較例6は粉体分散性が良いと言われている油剤(ポリヒドロキシステアリン酸)をさらに配合した処方である。また、比較例7〜10は(C)ポリ(12−ヒドロキシステアリン酸)エステルの配合に代えて、界面活性剤であるジイソステアリン酸ポリグリセリル−3、セスキイソステアリン酸ソルビタンを配合した処方である。比較例11は、もともと処方されていた界面活性剤(トリイソステアリン酸ポリグリセリル−2)を増量させた処方である。
また、表中の顔料1と顔料2は、顔料の粒子径により分けて表記した。粒子径が50nm以下の微粒子顔料を顔料2とし、それよりも大きい通常サイズの顔料を顔料1とした。
Hereinafter, the present invention will be described in more detail by showing test examples using examples and comparative examples.
1. Preparation of Test Product A water-in-oil type milk composition (base makeup cosmetic) having a composition shown in Table 1 (Examples 1 to 6) and Table 2 (Comparative Examples 1 to 11) was prepared by the following preparation method.
Comparative Example 1 is a formulation in which (A) the organically modified clay mineral is not blended. Comparative Examples 2 and 3 are formulations in which (B) behenic acid / eicosantioic acid) glyceryl is not blended. Comparative Example 2 uses dextrin palmitate, which is an oily thickener, instead of glyceryl behenic acid / eicosantioic acid). It is a blended formula. Comparative Examples 4 to 11 are formulations that do not contain (C) poly (12-hydroxystearic acid) ester, whereas Comparative Example 4 increases the amount of surfactant (PEG-9 polydimethylsiloxyethyl dimethicone) originally formulated. Comparative Example 6 is a formulation further blended with an oil agent (polyhydroxystearic acid) which is said to have good powder dispersibility. Comparative Examples 7 to 10 are formulations in which (G) polyglyceryl-3 diisostearate and sorbitan sesquiisostearate are mixed instead of (C) poly (12-hydroxystearic acid) ester. Comparative Example 11 is a formulation in which the amount of the surfactant (polyglyceryl-2 triisostearate) originally formulated was increased.
Further, Pigment 1 and Pigment 2 in the table were separately described according to the particle diameter of the pigment. Pigment 2 was a fine particle pigment having a particle diameter of 50 nm or less, and Pigment 1 was a pigment of a normal size larger than that.
1.調製方法
油性成分と粉体を室温で混合し、ホモミキサー(3000rpm)で5分間混合した。混合物に水溶性成分を投入しながら、ホモミキサー(3000rpm)で混合し、1〜2分間乳化し、さらに5分間ホールドして調製を終了した。
1. Preparation Method The oily component and the powder were mixed at room temperature and mixed for 5 minutes using a homomixer (3000 rpm). While adding the water-soluble component to the mixture, the mixture was mixed with a homomixer (3000 rpm), emulsified for 1 to 2 minutes, and further held for 5 minutes to complete the preparation.
2.評価
表1、2の油中水型乳化組成物を、蓋付ガラス瓶(6K瓶)に充填し、5℃、25℃、40℃、50℃の恒温槽に保管し、調製翌日、1ヶ月後に開封し、充填表面の離油の発生の有無を目視観察した。またガラス瓶の側面を観察し、顔料の凝集による白スジの発生の有無を確認した。
さらに調製翌日、1ヶ月経過後の粘度を測定した。粘度は、東機産業(株)製のTV25型粘度計を使用し、4号ローター、12rpm、30秒の条件で25±2℃に保たれた環境にて粘度測定を行った。表中の粘度の単位はmPa・sである。
安定性(1.離油、2.白スジ)について、下記評価基準により外観を目視評価した。
(目視評価基準)
1.離油
○:離油がない
△:離油が極わずかにある
×:離油がはっきりしている
2.白スジ
○:白スジがない
△:白スジが極わずかにある
×:白スジがはっきりしている
2. Evaluation The water-in-oil emulsion compositions of Tables 1 and 2 were filled in a glass bottle with a lid (6K bottle) and stored in a thermostat at 5 ° C, 25 ° C, 40 ° C, and 50 ° C. It was opened and the filling surface was visually observed for the occurrence of oil separation. Further, the side surface of the glass bottle was observed to confirm whether or not white streaks were generated due to aggregation of the pigment.
Further, the day after the preparation, the viscosity was measured one month later. The viscosity was measured using a TV25 type viscometer manufactured by Toki Sangyo Co., Ltd. in an environment maintained at 25 ± 2 ° C. under conditions of a No. 4 rotor, 12 rpm, and 30 seconds. The unit of the viscosity in the table is mPa · s.
The stability (1. oil release, 2. white stripes) was visually evaluated for appearance according to the following evaluation criteria.
(Visual evaluation criteria)
1. Oil separation ○: No oil separation △: Very little oil separation ×: Clear oil separation White streaks ○: No white streaks △: Very few white streaks ×: White streaks are clear
3.結果
結果を下記の表3に示す。
3. Results The results are shown in Table 3 below.
1.実施例1〜6の組成物(A+B+C+D+E)
実施例の組成物は、製造翌日、及び5℃、25℃、40℃、50℃の恒温槽に1ヶ月間保管後のいずれの条件においても外観観察で安定性(白スジ、離油の出現)に異常は認められなかった。
1. Compositions of Examples 1 to 6 (A + B + C + D + E)
The compositions of the Examples were stable in appearance (white streaks, oil release) on the day after production and after storage for one month in a thermostat at 5 ° C, 25 ° C, 40 ° C, and 50 ° C. No abnormalities were observed.
2.比較例1の組成物(B+C+D+E)
比較例1の組成物は、A有機変性粘土鉱物を配合しない処方である。5℃、25℃、40℃、50℃の恒温槽に1ヶ月間保管後のいずれの条件においても外観観察で安定性(白スジ、離油の出現)に異常が認められた。離油と白スジは2週間経過後から観察されていた。
2. Composition of Comparative Example 1 (B + C + D + E)
The composition of Comparative Example 1 is a formulation that does not contain the A organic modified clay mineral. Under any condition after storage in a thermostat at 5 ° C., 25 ° C., 40 ° C., and 50 ° C. for one month, abnormalities were observed in the stability (appearance of white stripes and oil separation) in appearance observation. Oil release and white streaks were observed after 2 weeks.
3.比較例2の組成物(A+C+D+E)
比較例2の組成物は、B(ベヘン酸/エイコサン二酸)グリセリルに代えて油性増粘剤であるパルミチン酸デキストリンを配合した処方である。製造翌日には50℃保管で白スジが観察され、その後25℃、40℃でもわずかに白スジが観察された。比較例2は離油の発生はなかったが、白スジが発生するため、所望する組成物ではなかった。
3. Composition of Comparative Example 2 (A + C + D + E)
The composition of Comparative Example 2 was a formulation in which dextrin palmitate, which is an oily thickener, was added in place of glyceryl B (behenic acid / eicosantioic acid). On the day after production, white streaks were observed after storage at 50 ° C., and then slight white streaks were observed even at 25 ° C. and 40 ° C. In Comparative Example 2, although no oil separation occurred, white stripes were generated, and thus the composition was not a desired composition.
4.比較例3の組成物(A+C+D+E)
比較例3の組成物は、粘度が著しく低く、測定限界以下であり、シャパシャパの液状であった。離油、白スジ共に発生した。
4. Composition of Comparative Example 3 (A + C + D + E)
The composition of Comparative Example 3 was extremely low in viscosity, lower than the measurement limit, and was in the form of a liquid. Oil release and white streaks occurred.
5.比較例4〜6の組成物(A+B+D+E)
比較例4の組成物はポリ(12−ヒドロキシステアリン酸)エステルを配合せず、本試験で乳化のために一律に配合していた界面活性剤の一つであるPEG−9ポリジメチルシロキシエチルジメチコンを1質量%から2質量%に増量させて、白スジの発生が抑えられるか試験したものである。1ヶ月後の各温度帯において、白スジが発生した。比較例4の組成物に離油の発生はなかったが、白スジが発生するため、所望する組成物ではなかった。
比較例5の組成物はポリ(12−ヒドロキシステアリン酸)エステルを含まない組成であるが、50℃で離油が発生し、すべての温度帯で白スジが観察された。白スジは調製翌日(25℃)からわずかに認められた。
比較例6の組成物は、ポリ(12−ヒドロキシステアリン酸)エステルを配合せず、粉体の分散が良いと言われている油剤(ポリヒドロキシステアリン酸)を1質量%配合して、白スジの発生が抑えられるか試験したものである。しかし、5℃、40℃、50℃保管1ヶ月後には、白スジが発生し、25℃1ヶ月保管後のものにもわずかに白スジが認められた。白スジは調製翌日(25℃)からわずかに認められた。比較例6の組成物に離油の発生はなかったが、白スジが発生するため、所望する組成物ではなかった。
5. Compositions of Comparative Examples 4 to 6 (A + B + D + E)
The composition of Comparative Example 4 did not contain poly (12-hydroxystearic acid) ester, and was one of the surfactants uniformly blended for emulsification in this test, PEG-9 polydimethylsiloxyethyl dimethicone. Was increased from 1% by mass to 2% by mass to test whether generation of white stripes can be suppressed. One month later, white streaks occurred in each temperature zone. Although no oil separation occurred in the composition of Comparative Example 4, the composition was not a desired composition because white streaks were generated.
Although the composition of Comparative Example 5 had no poly (12-hydroxystearic acid) ester, oil separation occurred at 50 ° C., and white stripes were observed in all temperature ranges. White streaks were slightly observed from the day after preparation (25 ° C.).
The composition of Comparative Example 6 contained 1% by mass of an oil agent (polyhydroxystearic acid), which is said to have a good powder dispersion without blending the poly (12-hydroxystearic acid) ester, and prepared a white stripe. The test was conducted to determine whether or not the occurrence of blemishes was suppressed. However, white streaks occurred after storage at 5 ° C., 40 ° C., and 50 ° C. for one month, and white streaks were slightly observed even after storage at 25 ° C. for one month. White streaks were slightly observed from the day after preparation (25 ° C.). Although no oil separation occurred in the composition of Comparative Example 6, the composition was not a desired composition because white streaks occurred.
6.比較例7〜11の組成物(A+B+D+E)
比較例7〜10は(C)ポリ(12−ヒドロキシステアリン酸)エステルの配合に代えて、界面活性剤であるジイソステアリン酸ポリグリセリル−3、セスキイソステアリン酸ソルビタンを配合した処方である。比較例11は、本試験で乳化のために一律に配合していた界面活性剤の1つであるトリイソステアリン酸ポリグリセリル−2を1質量%から2質量%に増量させた処方である。
比較例7の組成物は、5℃、25℃、40℃、50℃保管1ヶ月後には、白スジが発生し、50℃で1ヶ月保管後のものには離油が認められた。25℃の白スジは調製翌日からわずかに認められ、1ヶ月後にははっきりと白スジが認められた。
比較例8の組成物は、5℃、25℃、40℃、50℃保管1ヶ月後には、白スジが発生した。25℃の白スジは調製翌日からわずかに認められた。離油は発生しなかった。白スジが発生するため、所望する組成物ではなかった。
比較例9の組成物は、5℃、25℃、40℃、50℃保管1ヶ月後には、白スジが発生し、50℃に1ヶ月保管後のものには離油が認められた。25℃の白スジは調製翌日からわずかに認められた。
比較例10の組成物は、5℃、25℃、40℃、50℃保管1ヶ月後には、白スジが発生した。25℃の白スジは調製翌日からわずかに認められた。離油は発生しなかった。白スジが発生するため、所望する組成物ではなかった。
比較例11の組成物は、5℃、25℃、40℃、50℃保管1ヶ月後には、白スジが発生した。25℃の白スジは調製翌日からはっきりと確認された。離油は発生しなかった。
比較例4〜11の結果から、(C)ポリ(12−ヒドロキシステアリン酸)エステルの配合が白スジの発生を抑えるのに必須であることが分かった。
6. Compositions of Comparative Examples 7 to 11 (A + B + D + E)
Comparative Examples 7 to 10 are formulations in which polyglyceryl-3 diisostearate and sorbitan sesquiisostearate were mixed instead of (C) poly (12-hydroxystearic acid) ester. Comparative Example 11 is a formulation in which polyglyceryl-2 triisostearate, which is one of the surfactants uniformly mixed for emulsification in this test, was increased from 1% by mass to 2% by mass.
In the composition of Comparative Example 7, white streaks were generated after storage at 5 ° C., 25 ° C., 40 ° C., and 50 ° C. for one month, and oil release was observed after storage at 50 ° C. for one month. White stripes at 25 ° C. were slightly observed from the day after the preparation, and one month later, white stripes were clearly observed.
The composition of Comparative Example 8 generated white streaks after one month of storage at 5 ° C, 25 ° C, 40 ° C, and 50 ° C. White streaks at 25 ° C were slightly observed from the day after the preparation. No oil separation occurred. This was not the desired composition because white streaks occurred.
In the composition of Comparative Example 9, white streaks were generated after storage at 5 ° C., 25 ° C., 40 ° C., and 50 ° C. for one month, and oil release was observed after storage at 50 ° C. for one month. White streaks at 25 ° C were slightly observed from the day after the preparation.
The composition of Comparative Example 10 had white streaks after one month of storage at 5 ° C, 25 ° C, 40 ° C, and 50 ° C. White streaks at 25 ° C were slightly observed from the day after the preparation. No oil separation occurred. This was not the desired composition because white streaks occurred.
In the composition of Comparative Example 11, white streaks occurred after storage at 5 ° C, 25 ° C, 40 ° C, and 50 ° C for one month. White streaks at 25 ° C. were clearly confirmed from the day after the preparation. No oil separation occurred.
From the results of Comparative Examples 4 to 11, it was found that the blending of (C) poly (12-hydroxystearic acid) ester was essential for suppressing the occurrence of white stripes.
次に、さらに顔料の配合量を増やした実施例7、実施例8を同様の方法で調製し、粘度と安定性を測定し評価した。組成と結果を表4に示す。
(結果)
実施例7の油中水型乳化組成物は、顔料の配合量が実施例1〜6及び8よりも高く、27質量%である。さらに実施例7及び8の微粒子顔料の配合量に着目すると、実施例7は16質量%(微粒子酸化チタン純分で14質量%、微粒子酸化亜鉛2質量%)、実施例8は14質量%(微粒子酸化チタン純分で12質量%、微粒子酸化亜鉛2質量%)である。実施例1〜6が7.5質量%(微粒子酸化チタン純分で5.5質量%、微粒子酸化亜鉛2質量%)であるから微粒子顔料を約倍量以上配合した組成である。このような顔料の凝集が特に生じやすい組成であっても、実施例7、8は各温度帯(5℃、25℃、40℃、50℃)で1ヶ月間保管後に離油、白スジは全く発生しなかった。尚、調製翌日の粘度は、実施例7が43860mPa・s、実施例8が77700mPa・sであった。
(result)
In the water-in-oil emulsion composition of Example 7, the blending amount of the pigment was higher than Examples 1 to 6 and 8, and was 27% by mass. Further focusing on the blending amounts of the fine particle pigments of Examples 7 and 8, Example 7 has 16% by mass (14% by mass of fine particles of titanium oxide and 2% by mass of fine particles of zinc oxide), and Example 8 has 14% by mass ( 12% by mass of fine titanium oxide particles and 2% by mass of zinc oxide particles). Since Examples 1 to 6 are 7.5% by mass (5.5% by mass in terms of fine particles of titanium oxide and 2% by mass of fine particles of zinc oxide), the composition contains about twice or more of the fine particle pigment. Even with such a composition in which pigment aggregation is particularly likely to occur, Examples 7 and 8 show oil release and white streaks after storage for one month in each temperature zone (5 ° C, 25 ° C, 40 ° C, 50 ° C). Not at all. The viscosity on the day following preparation was 43860 mPa · s in Example 7, and 77700 mPa · s in Example 8.
以上、比較例1〜11の保存試験の評価結果、及び実施例1〜8の評価結果から、顔料を高濃度で含有する油中水型乳化組成物において、(A)有機変性粘土鉱物と(B)(ベヘン酸/エイコサン二酸)グリセリル及び(C)ポリ(12−ヒドロキシステアリン酸)エステル、(D)界面活性剤、(E)油剤の構成をとる油中水型乳化組成物は、離油発生を防止し、白スジの発生を抑制できることが明らかとなった。 As described above, from the evaluation results of the preservation tests of Comparative Examples 1 to 11 and the evaluation results of Examples 1 to 8, in the water-in-oil emulsion composition containing a pigment at a high concentration, (A) the organically modified clay mineral and ( B) glyceryl (behenic acid / eicosantioic acid) and (C) a poly (12-hydroxystearic acid) ester, (D) a surfactant, and (E) a water-in-oil emulsion composition comprising an oil agent. It has been clarified that generation of oil can be prevented and generation of white stripes can be suppressed.
本発明の構成をとる油中水型乳化組成物は、保存中に離油が生じず、さらに様々な粒子径の顔料が混在する組成において微粒子化した顔料の凝集に起因する白スジ、色ムラも発生せず、極めて安定性の高い化粧料とすることができた。本発明の構成をとることで50℃の苛酷条件下に保存しても、離油が発生せず、白スジや色ムラも発生しないので、肌色に調整した化粧料に、さらに紫外線防御効果を期待して微粒子酸化チタンや微粒子酸化亜鉛などの微粒子粉体を安心して高配合することができる。このため、本発明はベースメイクアップ化粧料や肌色に調整された日焼け止め化粧料の製品開発技術として非常に有用である。 The water-in-oil emulsion composition having the configuration of the present invention does not cause oil separation during storage, and further has white stripes and color unevenness caused by aggregation of finely divided pigments in a composition in which pigments having various particle diameters are mixed. No cosmetics were generated, and a highly stable cosmetic was obtained. By adopting the constitution of the present invention, even when stored under severe conditions of 50 ° C., oil release does not occur and white streaks and color unevenness do not occur. It is expected that fine particles such as fine particles of titanium oxide and fine particles of zinc oxide can be blended with high reliability. Therefore, the present invention is very useful as a product development technique for base makeup cosmetics and sunscreen cosmetics adjusted to skin color.
Claims (5)
(A)有機変性粘土鉱物
(B)(ベヘン酸/エイコサン二酸)グリセリル
(C)ポリ(12−ヒドロキシステアリン酸)エステル
(D)界面活性剤
(E)油剤
を含有する油中水型乳化組成物。 In a water-in-oil emulsion composition containing 15 to 30% by mass of a pigment,
(A) Organically modified clay mineral (B) (Behenic acid / eicosantioic acid) glyceryl (C) Poly (12-hydroxystearic acid) ester (D) Surfactant (E) Water-in-oil emulsion containing oil agent Stuff.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016068572A JP6674816B2 (en) | 2016-03-30 | 2016-03-30 | Water-in-oil emulsion composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016068572A JP6674816B2 (en) | 2016-03-30 | 2016-03-30 | Water-in-oil emulsion composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2017178848A JP2017178848A (en) | 2017-10-05 |
JP6674816B2 true JP6674816B2 (en) | 2020-04-01 |
Family
ID=60008429
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016068572A Active JP6674816B2 (en) | 2016-03-30 | 2016-03-30 | Water-in-oil emulsion composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6674816B2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6900415B2 (en) * | 2019-03-27 | 2021-07-07 | ちふれホールディングス株式会社 | Water-in-oil emulsified cosmetic |
WO2021132444A1 (en) | 2019-12-25 | 2021-07-01 | 花王株式会社 | Water-in-oil-type emulsified sunscreen cosmetic |
WO2024142911A1 (en) * | 2022-12-28 | 2024-07-04 | 株式会社 資生堂 | Water-in-oil emulsion cosmetic |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4332062B2 (en) * | 2004-04-23 | 2009-09-16 | 株式会社コーセー | Water-in-oil whitening cosmetic |
JP5366468B2 (en) * | 2008-08-01 | 2013-12-11 | 株式会社ノエビア | Water-in-oil emulsion composition |
JP5572356B2 (en) * | 2009-10-05 | 2014-08-13 | 株式会社ファンケル | Water-in-oil emulsified skin external preparation |
JP5824323B2 (en) * | 2011-10-26 | 2015-11-25 | 株式会社ファンケル | Water-in-oil emulsion composition |
JP6133618B2 (en) * | 2013-02-21 | 2017-05-24 | 株式会社ファンケル | Water-in-oil emulsion composition |
JP6250465B2 (en) * | 2014-04-21 | 2017-12-20 | 日本メナード化粧品株式会社 | Water-in-oil emulsified cosmetic |
-
2016
- 2016-03-30 JP JP2016068572A patent/JP6674816B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2017178848A (en) | 2017-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4881961B2 (en) | Oil-in-water sunscreen cosmetics | |
KR100621383B1 (en) | Sunscreen composition | |
EP2915524B1 (en) | Sunscreen cosmetic | |
JP5808083B2 (en) | Sunscreen cosmetics | |
WO2007060823A1 (en) | External preparation for skin | |
WO2010070867A1 (en) | Titanium oxide dispersion and cosmetics wherein same is blended | |
JP6887765B2 (en) | Sunscreen cosmetics | |
WO2019004048A1 (en) | Water break-type sunscreen cosmetic product | |
JP2016153437A (en) | Water-in-oil type emulsion cosmetic | |
JP6359295B2 (en) | Water-in-oil emulsified cosmetic and method for producing the same | |
JP6674816B2 (en) | Water-in-oil emulsion composition | |
JP2013071931A (en) | Water-in-oil type emulsified cosmetic | |
JP5792493B2 (en) | Water-in-oil emulsified cosmetic | |
JP7347993B2 (en) | sunscreen composition | |
KR102715221B1 (en) | Make-up cosmetic composition comprising scoria powder | |
JP2015189671A (en) | Water-in-oil emulsion cosmetic preparation | |
JP2007161708A (en) | O/w emulsified cosmetic | |
KR20210144773A (en) | Oil-based mixed composition, cosmetics and method for manufacturing cosmetics | |
JP2017137300A (en) | Oil-in-water type emulsion cosmetic | |
JP6894628B2 (en) | Water-in-oil emulsified cosmetic | |
JP6831737B2 (en) | Underwater oil type cosmetics | |
JP6900415B2 (en) | Water-in-oil emulsified cosmetic | |
JP6866412B2 (en) | Water-in-oil emulsified cosmetic | |
JP6267032B2 (en) | Sunscreen cosmetics | |
JP4767640B2 (en) | Low viscosity oil-in-water emulsified cosmetic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20181023 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20190821 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190827 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20191021 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20200225 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20200309 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6674816 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |